A 45-year-old man developed cerebral vasculitis associated with a systemic hypersensitivity response shortly after commencing treatment with allopurinol. The illness settled on withdrawal of the drug and no other cause was found. Keywords: allopurinol, cerebral vasculitis Allopurinol is a xanthine oxidase inhibitor which is widely used in the treatment and prophylaxis of hyperuricaemia. 
Allopurinol is a xanthine oxidase inhibitor which is widely used in the treatment and prophylaxis of hyperuricaemia. Common sideeffects include skin rash and gastrointestinal symptoms,' but less commonly hypersensitivity may occur in the form of a generalised vasculitis causing eosinophilia, fever, exfoliative dermatitis2 and, if severe, hepatic, ocular and renal damage.3-5 Neurological manifestations are rare,6 although there have been isolated reports of peripheral neuropathy.7 '8 We report a case of vasculitis associated with allopurinol treatment with prominent central nervous system (CNS) manifestations.
Case report
A 45-year-old man suffering from low grade small cell follicular lymphoma was commenced on chlorambucil (10 mg/day for two weeks) and prophylactic allopurinol (300 mg/day). Three weeks later he developed frontal headache, nausea and a maculopapular rash on trunk and limbs, followed by progressive weakness of his right arm and left leg and paraesthesia in both hands. The allopurinol was stopped, he was treated with antihistamines and referred for neurological investigation. There were no other medications, and no significant past medical history or family history.
Examination Investigation revealed a marked eosinophilia (23 x 109/1), an elevated erythrocyte sedimentation rate (45 mm/h) and C-reactive protein (13.1 mg/dl). Serum IgA, IgM and IgG were reduced, and immune complexes were detected in the blood. Cryoglobulins were not detected. Anti-nuclear factor, rheumatoid factor, and anti-neutrophil cytoplasmic antibody were negative. Anti-streptolysin 0 titre, plasma viscocity, and B12 and folate were normal, and blood cultures, tests for hepatitis B, mycoplasma and toxoplasma infection were negative. An electrocardiogram, chest X-ray and echocardiogram were normal. Urea, creatinine and urine microscopy were normal, and liver function tests were within normal limits. A computed tomography (CT) brain scan was normal, but magnetic resonance imaging (MRI) revealed multiple large discrete periventricular lesions of high signal intensity on T-2 weighted images, compatible with vasculitis or demyelination (figure). Cerebrospinal fluid pressure, microscopy, culture, cytology, protein, glucose and electrophoresis were normal, with a low IgG concentration and no oligoclonal bands. Sural and median nerve sensory action potentials were absent and electromyography showed an excess of polyphasic units, consistent with a distal axonal neuropathy.
Within days of stopping the allopurinol the headache and rash subsided, and after one 
A repeat MRI six months later showed resolution of the previous abnormalities. Over the subsequent year he required further treatment for his lymphoma but had no further neurological symptoms.
Discussion
The patient's systemic upset began shortly after starting allopurinol treatment, was similar to previously reported allopurinol hypersensitivity reactions, and resolved rapidly on withdrawal of the drug. Chlorambucil is not reported to cause vasculitis. Vasculitis can occasionally occur in association with systemic lymphoma in the absence of other potential causes, but is usually limited to the skin,9 although a vasculitic sensorimotor polyneuropathy has been reported.'0 In this case, the rapid resolution of symptoms without further treatment suggests that lymphoma was not the cause. The MRI scan appearance was not that of primary CNS lymphoma, and the rapid neurological improvement was not consistent with cerebral involvement. The MRI appearance could be due to demyelination, but the clinical syndrome was not typical, there was no history ofprevious episodes, and analysis ofthe cerebrospinal fluid revealed no evidence of demyelination. The detection of immune complexes in the serum is consistent with the finding of immune complex deposition in allopurinol hypersensitivity vasculitis."1
We are not aware of any previous reports of symptomatic cerebral vasculitis in association with allopurinol treatment. Retinal vasculitis and biopsy-proven temporal arteritis were reported in one case,4 and a patient with renal carcinoma taking deoxycoformycin and allopurinol developed generalised small vessel arteritis which was found to involve the cerebral vessels at post mortem, although this had not been clinically evident. ' 
